Processa Pharmaceuticals Statistics
Share Statistics
Processa Pharmaceuticals has 11.88M
shares outstanding. The number of shares has increased by 29.84%
in one year.
Shares Outstanding | 11.88M |
Shares Change (YoY) | 29.84% |
Shares Change (QoQ) | 0.34% |
Owned by Institutions (%) | 4.19% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 10,018 |
FTD / Avg. Volume | 0.39% |
Short Selling Information
The latest short interest is 70.23K, so 1.33% of the outstanding
shares have been sold short.
Short Interest | 70.23K |
Short % of Shares Out | 1.33% |
Short % of Float | 1.49% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.23 and the forward
PE ratio is -0.28.
Processa Pharmaceuticals's PEG ratio is
0.
PE Ratio | -0.23 |
Forward PE | -0.28 |
PS Ratio | 0 |
Forward PS | 0 |
PB Ratio | 1.59 |
P/FCF Ratio | -0.24 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Processa Pharmaceuticals.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22,
with a Debt / Equity ratio of 0.04.
Current Ratio | 1.22 |
Quick Ratio | 1.22 |
Debt / Equity | 0.04 |
Debt / EBITDA | -0.01 |
Debt / FCF | -0.01 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-1,185,011.8 |
Employee Count | 10 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -86.36% in the
last 52 weeks. The beta is 1.35, so Processa Pharmaceuticals's
price volatility has been higher than the market average.
Beta | 1.35 |
52-Week Price Change | -86.36% |
50-Day Moving Average | 0.3 |
200-Day Moving Average | 0.87 |
Relative Strength Index (RSI) | 44.62 |
Average Volume (20 Days) | 2,598,738 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.05M |
Net Income | -11.85M |
EBITDA | -11.85M |
EBIT | -11.85M |
Earnings Per Share (EPS) | -3.62 |
Full Income Statement Balance Sheet
The company has 1.19M in cash and 73.51K in
debt, giving a net cash position of 1.12M.
Cash & Cash Equivalents | 1.19M |
Total Debt | 73.51K |
Net Cash | 1.12M |
Retained Earnings | -87.22M |
Total Assets | 4.81M |
Working Capital | 2.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -11.25M
and capital expenditures -3.24K, giving a free cash flow of -11.25M.
Operating Cash Flow | -11.25M |
Capital Expenditures | -3.24K |
Free Cash Flow | -11.25M |
FCF Per Share | -3.68 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |